We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$52.9M
2
WST icon
West Pharmaceutical
WST
+$39.7M
3
AMED
Amedisys
AMED
+$36.8M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34M
5
SPOT icon
Spotify
SPOT
+$34M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRU icon
26
TransUnion
TRU
$16B
$98.9M 0.76%
1,135,885
– –
ALGN icon
27
Align Technology
ALGN
$12.9B
$96.3M 0.74%
351,047
+96,986
+38% +$21.8M
RP
28
DELISTED
RealPage, Inc.
RP
$93.4M 0.72%
1,436,703
-110,851
-7% -$6.99M
KWR icon
29
Quaker Houghton
KWR
$2.58B
$93.3M 0.72%
502,693
-180,748
-26% -$28.4M
IDXX icon
30
Idexx Laboratories
IDXX
$44.9B
$93.3M 0.72%
282,506
– –
BURL icon
31
Burlington
BURL
$23.4B
$92M 0.71%
467,368
-50,742
-10% -$9.56M
MRVL icon
32
Marvell Technology
MRVL
$147B
$85.7M 0.66%
2,444,983
-132,675
-5% -$3.88M
KEYS icon
33
Keysight
KEYS
$50.7B
$85.1M 0.66%
844,114
-1,900
-0.2% -$187K
MASI
34
DELISTED
Masimo
MASI
$84.7M 0.65%
371,397
-49,862
-12% -$10.9M
COHR
35
DELISTED
Coherent Inc
COHR
$84.4M 0.65%
644,054
-21,430
-3% -$2.81M
LHX icon
36
L3Harris
LHX
$55.4B
$83.2M 0.64%
490,164
– –
DXCM icon
37
DexCom
DXCM
$29B
$81.8M 0.63%
807,088
-372,216
-32% -$33.3M
MCHP icon
38
Microchip Technology
MCHP
$38.8B
$80.7M 0.62%
1,531,998
– –
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$11.9B
$80.2M 0.62%
650,076
+102,476
+19% +$10.2M
MSFT icon
40
Microsoft
MSFT
$2.9T
$80M 0.62%
392,902
-50,859
-11% -$9.23M
CZR
41
DELISTED
Caesars Entertainment Corporation
CZR
$77.6M 0.6%
6,394,314
-128,607
-2% -$1.3M
MLM icon
42
Martin Marietta Materials
MLM
$34.2B
$77.5M 0.6%
375,236
-20,700
-5% -$3.98M
AMED
43
DELISTED
Amedisys
AMED
$77.2M 0.59%
388,749
+197,247
+103% +$36.8M
ZEN
44
DELISTED
ZENDESK INC
ZEN
$76.9M 0.59%
868,891
– –
TWTR
45
DELISTED
Twitter, Inc.
TWTR
$76.3M 0.59%
2,560,280
-374,126
-13% -$11.3M
FND icon
46
Floor & Decor
FND
$6.03B
$75.3M 0.58%
1,305,706
+96,878
+8% +$4.42M
TFX icon
47
Teleflex
TFX
$5.96B
$75.1M 0.58%
206,292
-2,525
-1% -$872K
SGEN
48
DELISTED
Seagen Inc. Common Stock
SGEN
$72.5M 0.56%
426,867
– –
AJRD
49
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$72.4M 0.56%
1,825,609
– –
URI icon
50
United Rentals
URI
$65.7B
$71.2M 0.55%
477,570
+16,125
+3% +$2.05M
1
2
3 4 5

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.